In summary, our study provides new evidence that B7-H3 is associated with one of the key rate-limiting metabolic enzymes IMPDH2, and this complex localises to intracellular RRs in normal epithelia and the plasma membrane in cancer cells that overexpress B7-H3. This evidence concerns the gene CD276 and cancer.